FDA OKs Monthly Multiple Sclerosis Drug: Zinbryta
There’s now a once-a-month injection for treating relapsing multiple sclerosis. The drug is called Zinbryta (daclizumab) and it was just approved by the Food and Drug Administration. Zinbryta is self-administered subcutaneously, which means using needles that are shorter than the ones that are used for drugs, such as Avonex, which are administered into the muscle. Clinical data, reported by Zinbryta’s manufacturer, Biogen, shows Zinbryta significantly reduced relapses and brain lesions…Continue Reading